deltatrials
Completed NA INTERVENTIONAL 1-arm NCT01307501

Safety and Efficacy of Cryoablation for Metastatic Lung Tumors (ECLIPSE)

Evaluating Cryoablation of Metastatic Lung/Pleura Tumors in Patients - Safety and Efficacy

Sponsor: Boston Scientific Corporation

Conditions Metastatic Lung Cancer
Interventions Cryoablation
Updated 15 times since 2017 Last updated: Jul 15, 2021 Started: Jan 4, 2012 Primary completion: Aug 30, 2018 Completion: Aug 30, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01307501, this NA trial focuses on Metastatic Lung Cancer and remains completed. Sponsored by Boston Scientific Corporation, it has been updated 15 times since 2012, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Jun 2017 · 5 months · monthly snapshot~Jun 2017 – ~Aug 2017 · 2 months · monthly snapshot~Aug 2017 – ~Jun 2018 · 10 months · monthly snapshot~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshot~Sep 2018 – ~Mar 2019 · 6 months · monthly snapshot~Mar 2019 – ~Nov 2019 · 8 months · monthly snapshot~Nov 2019 – ~Feb 2020 · 3 months · monthly snapshot~Feb 2020 – ~Jul 2020 · 5 months · monthly snapshot~Jul 2020 – ~Aug 2020 · 31 days · monthly snapshot~Aug 2020 – ~Jan 2021 · 5 months · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Sep 2021 · 7 months · monthly snapshot~Sep 2021 – ~Jul 2024 · 34 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

15 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Sep 2021 — Jul 2024 [monthly]

    Completed NA

  4. Feb 2021 — Sep 2021 [monthly]

    Completed NA

  5. Jan 2021 — Feb 2021 [monthly]

    Completed NA

▶ Show 10 earlier versions

  1. Aug 2020 — Jan 2021 [monthly]

    Completed NA

  2. Jul 2020 — Aug 2020 [monthly]

    Completed NA

  3. Feb 2020 — Jul 2020 [monthly]

    Completed NA

  4. Nov 2019 — Feb 2020 [monthly]

    Completed NA

  5. Mar 2019 — Nov 2019 [monthly]

    Completed NA

    Status: Active Not Recruiting → Completed

  6. Sep 2018 — Mar 2019 [monthly]

    Active Not Recruiting NA

  7. Jun 2018 — Sep 2018 [monthly]

    Active Not Recruiting NA

  8. Aug 2017 — Jun 2018 [monthly]

    Active Not Recruiting NA

  9. Jun 2017 — Aug 2017 [monthly]

    Active Not Recruiting NA

    Phase: PHASE1 → NA

  10. Jan 2017 — Jun 2017 [monthly]

    Active Not Recruiting PHASE1

    First recorded

Jan 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Boston Scientific Corporation
Data source: Boston Scientific Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations